Logo

Rosetta Licenses Resolver to Abbott Labs

Mar 25, 2002

NEW YORK, March 25 - Rosetta Biosoftware on Monday said it has licensed its Resolver gene-expression data-analysis system to Abbott Laboratories.

 

Financial terms of the deal were not disclosed, though Agilent Technologies, as usual, will distribute the bioinformatics tool.

 

The agreement is the second one in as many weeks for Rosetta, which licensed the Resolver system to Genencor on March 11.

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.